ACMD reply IC-494733-Z9F5 filed 20 April 2026 letter undated
- Authority case reference
- IC-494733-Z9F5
Open or download the complete original
ACMD evidence and current review
- ACMD reply IC-494733-Z9F5 filed 20 April 2026 letter undated
- Home Office ACMD work programme commission 2 June 2025
- ACMD call for evidence 17 September 2025
- ACMD call for evidence questionnaire
- ACMD work programme update 21 September 2026
- JBD email as sent to ACMD 16 October 2025
- DHSC FOI 1652371 reply 13 November 2025
Document text
The complete original retains the page layout and any redactions.
PDF page 1
Dear Pete Lindsay (cc Information Commissioner’s Office) Thank you for your e-mail dated 12th January 2026. We are sorry for providing a late response as owing to email quarantine, your request was not seen until the Information Commissioner’s Office had contacted us directly. Your request has been handled as a request for information under the Freedom of Information Act 2000 (FOIA). 1. Understanding of commission scope and limits Please see ACMD advice of 19 July 2018 on how ACMD understood the scope of the July 2018 commission. No information held on other components of the question. 2. Route of administration and smoking Please see EMCDDA’s report: “Cannabis legislation in Europe: an overview” which refers to reasons why “no country authorises the smoking of cannabis for medical purposes” Route of administration was referred to on Page 7 in the ACMD advice of 11 September 2018, where it says “The ACMD does not anticipate that smoking will be a permissible route of administration of a CDMP as there is evidence of harms associated with smoking Cannabis”, with this associated reference: Lee, M. and Hancox, R. J. (2011) ‘Effects of smoking cannabis on lung function’, Expert Review of Respiratory Medicine, 5:4, pp 537–547. No information held on other components of the question. 3. Awareness of criminal law consequences No information held. 4. Scientific advice vs policy implementation No information held. 5. Emergency and self-administration contexts No information held.
PDF page 2
6. Equality and vulnerable cohorts No information held. 7. Engagement with or commentary on the Explanatory Memorandum and/or impact assessment accompanying SI No information held. 8. Post-implementation review and scope constraints Please see ACMD advice of 23 December 2019 and 27 November 2020 for ACMD’s role post-implementation. No information held on other components of the question. 9. Section 12 safeguards Section 12 of the FOI Act was not engaged in compiling this response. Yours sincerely, ACMD Secretariat